B. Lisboa

Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.

N. Brünner, M. Fernö, J. Foekens, 2002, Journal of the National Cancer Institute.

Molecular and immunohistochemical analysis of p53 mutations in scrapings and tissue from preinvasive and invasive breast cancer

L. Riethdorf, T. Löning, B. W. Lisboa, 1997, Virchows Archiv.

Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer

R. Wirtz, F. Jänicke, V. Müller, 2008, Breast Cancer Research and Treatment.

Pooled analysis of prognostic impact of uPA and PAI-1 in breast cancer patients

N. Brünner, M. Fernö, J. Foekens, 2003, Thrombosis and Haemostasis.

Expression pattern of the AP‐1 family in breast cancer: Association of fosB expression with a well‐differentiated, receptor‐positive tumor phenotype

K. Milde-Langosch, T. Löning, A. Bamberger, 1999, International journal of cancer.

CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer.

K. Friedrichs, B. W. Lisboa, U. Günthert, 1995, Cancer research.

Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue

W. Wilczak, D. Lüdecke, U. Knappe, 2003, Acta Neuropathologica.

Differential Expression of CD66a (BGP), a Cell Adhesion Molecule of the Carcinoembryonic Antigen Family, in Benign, Premalignant, and Malignant Lesions of the Human Mammary Gland

L. Riethdorf, T. Löning, B. W. Lisboa, 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.